Sleep

Why Sleep Apnea Looks Different in Women

Save

Loud snoring is not the only way sleep apnea shows up — and for many women it is not the way it shows up at all. Here is why the condition gets missed in women specifically, what the screening tools were built on, and how to get an evaluation even without the classic picture.

Last updated: July 2026

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

Why does sleep apnea look different in women?

Sleep apnea in women often does not look like the textbook picture of loud snoring and witnessed breathing pauses that shaped how the condition was first studied and diagnosed. Many clinicians describe women more often reporting fatigue, insomnia-like symptoms, morning headaches, or low mood — a symptom cluster that overlaps heavily with depression or simple overwork, and one that is far less likely to prompt a sleep-apnea work-up than a partner's complaint about snoring.

None of this means the underlying disease process is different; it means the presentation and the way it gets noticed by others differ enough to change who ends up getting tested. A woman whose apnea shows up as unrefreshing sleep and daytime exhaustion, rather than dramatic snoring, is easy to send toward a depression or thyroid work-up instead of a sleep study — and both of those are reasonable first guesses that can still leave the actual cause unaddressed for years.

The diagnostic tools were built on a mostly male picture

One structural reason for the gap sits in the screening tools themselves. STOP-Bang, the most widely used sleep apnea screening questionnaire, scores eight weighted factors — snoring, tiredness, observed breathing pauses, blood pressure, body size, age, neck size, and sex — and being male is literally one of the eight points that raises a person's score 1.

That is not a flaw exactly; sex is a genuine, measured risk factor built from the population the tool was validated against. But it means two people with an identical symptom burden can land on different sides of the referral threshold simply because one of them is a woman, since she starts the score one point behind on a factor she cannot change. A screening tool doing exactly what it was built to do can still under-flag a population it was not centered on.

How common is this, and how much of it goes unrecognized?

Underdiagnosis is not a women-specific problem — it is the norm for sleep apnea overall. A widely cited modeling analysis estimated that close to one billion adults worldwide have obstructive sleep apnea, with the large majority never diagnosed 2. Within that enormous undiagnosed group, the diagnostic and structural gaps described above give women a further reason to be overrepresented.

Hormonal shifts add another layer: sleep apnea becomes markedly more common in women after menopause, when the airway-protective effect of certain hormones declines, so a woman who never fit the risk profile in her thirties can develop real disease in her fifties without anyone thinking to reconsider. Age and life stage change the risk calculation in ways that a single, one-time screening threshold does not always capture.

The research gap behind the diagnostic gap

Part of the reason clinical thinking about sleep apnea skewed male for so long is that a lot of the foundational research did too. One of the landmark studies on cardiovascular outcomes in untreated sleep apnea — showing markedly higher cardiovascular event rates in people with severe, untreated disease — enrolled men exclusively 3.

That is not a criticism of the study, which was rigorous within its scope; it is a reminder that decades of what clinicians learned about what untreated apnea does to the body was learned primarily by watching it happen in men. Newer research increasingly includes women, but the accumulated weight of the older evidence base is part of why the disease was, for years, taught and recognized as a male condition first.

Getting evaluated

Evaluation follows the same path regardless of sex: a clinical history, then an actual sleep study to confirm the diagnosis, never a symptom checklist alone. Guidelines describe polysomnography, the in-lab study, as the diagnostic standard, with a home sleep apnea test available for adults who are otherwise healthy and at increased risk of moderate-to-severe disease 4.

National guidance does not recommend testing every adult with no symptoms at all, since the evidence to justify screening a fully asymptomatic population is not considered sufficient 5. That caveat is about blanket screening, not about someone with real fatigue, morning headaches, or a partner noticing pauses in breathing — bringing those symptoms up, even without loud snoring, is a legitimate reason to ask for an evaluation.

Treatment works the same way once diagnosed

Once diagnosed, treatment does not differ by sex. CPAP — continuous positive airway pressure — is the first-line therapy guidelines recommend for adults with obstructive sleep apnea, and it works by the same mechanism regardless of who is wearing the mask: keeping the airway open so sleep stops fragmenting 6.

People who cannot tolerate CPAP have other recognized options, including a custom oral appliance or, for selected cases, an implanted nerve-stimulation device. The larger point of this page is not the treatment, which is well established — it is getting to the diagnosis in the first place, since a condition that is this treatable only helps the people who get tested for it.

What else gets missed when apnea in women goes unrecognized

A missed diagnosis in women does not just mean untreated snoring — it means the downstream effects go unrecognized too, and they tend to get attributed to something else. The apnea brain fog that shows up as slower thinking and word-finding trouble gets chalked up to stress or parenting exhaustion; the risk of apnea and drowsy driving does not disappear just because the underlying condition was never named; and the general list of sleep apnea risk factors that clinicians check often weighs weight and neck size more heavily than the subtler picture many women present with.

Weight is a genuine risk factor, but it is not the whole story — non-obese sleep apnea is real and probably under-recognized in women specifically, since a smaller jaw, a naturally narrower airway, or hormonal shifts around menopause can produce disease without the body-size cue that clinicians are trained to look for first. None of that means every woman with fatigue has sleep apnea; it means the condition deserves to stay on the list even when the classic picture is missing.

Common questions

Yes, structurally. STOP-Bang, the most widely used screening questionnaire, includes sex as one of its eight scored factors, and being male adds a point that being female does not. That means a woman with the same symptoms as a man can score lower and be less likely to be flagged for a sleep study, even though the underlying disease process is identical.

Fatigue, insomnia-like difficulty sleeping, morning headaches, low mood, and unrefreshing sleep are commonly reported, often without the loud snoring or witnessed breathing pauses most people associate with sleep apnea. That symptom cluster overlaps heavily with depression and thyroid disease, which is part of why it gets misattributed for years.

Sleep apnea becomes markedly more common in women after menopause, as the airway-protective effect of certain hormones declines. A woman who never fit the risk profile in her thirties can develop real disease in her fifties, which is a reason to reconsider the possibility even without new risk factors like weight gain.

Not by default. National guidance does not recommend testing every adult with no symptoms, but that caveat is about population-wide screening, not about someone with real fatigue, morning headaches, or a partner noticing breathing pauses. Reporting those symptoms, even without loud snoring, is a legitimate reason to ask for an evaluation.

No. Diagnosis and treatment work the same way regardless of sex — a sleep study confirms it, and CPAP is the first-line treatment either way. The gap is almost entirely about who gets referred for testing in the first place, not about how the condition is managed once it is found.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

When fatigue or headaches need more than "you're just tired"

  • —Falling asleep involuntarily while driving, at work, or mid-conversation.
  • —A bed partner witnessing pauses in breathing followed by gasping or choking, especially with a racing or irregular heartbeat.
  • —Morning headaches with blood pressure that will not come under control on medication.

If you catch yourself nodding off while driving, stop driving and arrange an urgent evaluation before you drive again; call 911 for chest pain, fainting, or a sudden irregular heartbeat.

This article explains why sleep apnea is underdiagnosed in women for educational purposes and is not medical advice. Whether fatigue, headaches, or other symptoms are caused by sleep apnea depends on an actual evaluation, which belongs with a qualified clinician.

References

  1. 1.Chung F, Yegneswaran B, Liao P, et al. (2008). STOP questionnaire: a tool to screen patients for obstructive sleep apnea. Anesthesiology. doi:10.1097/ALN.0b013e31816d83e4 ✓Original development and validation of the STOP-Bang questionnaire and its component items (snoring, tiredness, observed apnea, pressure, BMI, age, neck, gender), in which male gender is one of the eight scored risk factors.
  2. 2.Benjafield AV, Ayas NT, Eastwood PR, et al. (2019). Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. The Lancet Respiratory Medicine. doi:10.1016/S2213-2600(19)30198-5 ✓Modeling estimate that close to one billion adults worldwide have obstructive sleep apnea, with most cases undiagnosed.
  3. 3.Marin JM, Carrizo SJ, Vicente E, Agusti AGN (2005). Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. The Lancet. doi:10.1016/S0140-6736(05)71141-7 ✓Landmark observational cohort on cardiovascular outcomes in untreated severe OSA was conducted in men exclusively, illustrating that foundational apnea research skewed toward male participants.
  4. 4.Kapur VK, Auckley DH, Chowdhuri S, Kuhlmann DC, Mehra R, Ramar K, Harrod CG (2017). Clinical Practice Guideline for Diagnostic Testing for Adult Obstructive Sleep Apnea: An American Academy of Sleep Medicine Clinical Practice Guideline. Journal of Clinical Sleep Medicine. doi:10.5664/jcsm.6506 ✓AASM guideline: polysomnography is the standard diagnostic test for OSA, with home sleep apnea testing an option for uncomplicated adults at increased risk of moderate-to-severe disease.
  5. 5.US Preventive Services Task Force (Mangione CM, et al.) (2022). Screening for Obstructive Sleep Apnea in Adults: US Preventive Services Task Force Recommendation Statement. USPSTF / JAMA. link ✓USPSTF 'I' statement: current evidence is insufficient to assess screening asymptomatic adults for OSA, a caveat about population screening rather than about testing symptomatic or at-risk individuals.
  6. 6.Patil SP, Ayappa IA, Caples SM, Kimoff RJ, Patel SR, Harrod CG (2019). Treatment of Adult Obstructive Sleep Apnea with Positive Airway Pressure: An American Academy of Sleep Medicine Clinical Practice Guideline. Journal of Clinical Sleep Medicine. doi:10.5664/jcsm.7640 ✓AASM guideline recommending PAP (CPAP/APAP/BPAP) as first-line therapy for adults with OSA to treat sleepiness and improve quality of life, regardless of sex.

6 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy

← Back to the health library